Café

CLDI

0.10474.38%( -0.0048 )

LongbridgeAI

CLDI

0.10474.38%( -0.0048 )

Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers

Unusual Whales

Jul 21, 2026 at 07:10 AM

On July 21, 2026, Calidi Biotherapeutics, Inc. (NYSE American: CLDI), a leading biotech firm, shared their accomplishments and future goals for 2026. The company specializes in advanced genetic therapies.

Source: Unusual Whales The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Calidi Biotherapeutics

CLDI.US

Open

High

Low

Prev Close

P/E^TTM

Market Cap